Graduate School :
Department: Pediatrics-Neurology
- PsyD, The Virginia Consortium Program in Clinical Psychology (1998)
- BA, American University (DC) (1992)
- Children's Hospital of Michigan Program (1998)
- Nationwide Children's Hospital/Ohio State University Program, Pediatric Neuropsychology (2000)
Department: Pediatrics-Neurology
Professional Titles
- Program Director, Neurofibromatosis Program
Research Interests
I am interested in investigating the development of cognitive skills in children with genetic disorders. I am also interested in exploring better ways of assessing cognitive functioning in children.
Publications
- Thompson, T., Stinnett, N., Tartaglia, N., Davis, S. & Janusz, J. (2022). ’I wish the school had a better understanding of the diagnosis’: Parent perspectives on educational needs for students with sex chromosome aneuploidies. Journal of Special Education Needs. DOI: 10.1111/1471-3802.12558
- Thompson T, Davis S, Janusz J, Frith E, Pyle L, Howell S, Boada R, Wilson R, Tartaglia N. (2022). Supporting students with sex chromosome aneuploidies in educational settings: Results of a nationwide survey. Journal of School Psychology, 93, 28-40. doi: 10.1016/j.jsp.2022.06.002.
- Boada, C., Thompson, T., Wilson, R., the eXtraordinarY Babies Study Team, Ross, J., Tartaglia, N., Janusz, J. The eXtraordinarY Babies Study: Early adaptive skills profiles of infants and toddlers with prenatally identified sex chromosome trisomies. Poster presentation for the 3rd International Workshop on Klinefelter syndrome, Trisomy X, and XYY, September 2022, Leiden, Netherlands.
- Janusz, J., Walsh, K., Klein-Tasman, B. International collaboration to identify endpoints for clinical trials in NF1. Poster presentation at the annual meeting of the International Neuropsychological Society February 2022, New Orleans, LA.
- Janusz J, Klein-Tasman BP, Payne JM, Wolters PL, Thompson HL, Martin S, de Blank P, Ullrich N, Del Castillo A, Hussey M, Hardy KK, Haebich K, Rosser T, Toledo-Tamula MA, Walsh KS; REiNS International Collaboration (2021). Recommendations for social skills endpoints for clinical trials in neurofibromatosis type 1. Neurology, 97, S73-80. doi: 10.1212/WNL.0000000000012422.
- Klein-Tasman BP, Lee K, Thompson HL, Janusz J, Payne JM, Pardej S, de Blank P, Kennedy T, Janke KM, Castillo AD, Walsh KS; REiNS International Collaboration (2021). Recommendations for measurement of attention outcomes in preschoolers with neurofibromatosis. Neurology, 97, S81-90. doi: 10.1212/WNL.0000000000012423.
- Thompson, T., Stinnett, N., Tartaglia, N., Davis, S. & Janusz, J. (in press). ’I wish the school had a better understanding of the diagnosis’: Parent perspectives on educational needs for students with sex chromosome aneuploidies. Journal of Special Education Needs.
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
Hospital Affiliation
- Children's Hospital Colorado
Specialty Information
Specialties
- Neuropsychology, Board Certification (2004)
- Licensed Psychologist, State of Colorado, License (2006)
- Board Certification in Clinical Neuropsychology, Board Certification (2004)
- Brain and Nervous System
- Child and Teen Health
- Mental Health and Behavior
- Genetic Conditions and Testing
Clinical Interests
I am interested in the neuropsychological effects of genetic and metabolic disorders. As the Program Director for the Neurofibromatosis (NF) Program, I have worked with our team to develop inter-disciplinary clinics that provide specialized care for children based on their medical, cognitive, and behavioral needs. I am involved with the Children's Tumor Foundation (CTF) in promoting clinical care for people with NF, and I currently serve as a member of the CTF Clinical Care Advisory Board. I am also the current chair of the Neurocognitive Committee of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration, which is focused on identifying standardized ways of conducting clinical trials in NF. In addition to working with children with NF, I am also a member of the 22q11.2 Deletion Syndrome Clinic and the eXtraordinarY Kids Clinic, a program for children with XY variants.
Care Philosophy
I strive to collaborate with families, physicians, and other health providers to help children reach their full potential in their social, academic, and behavioral functioning.
I am interested in the neuropsychological effects of genetic and metabolic disorders. As the Program Director for the Neurofibromatosis (NF) Program, I have worked with our team to develop inter-disciplinary clinics that provide specialized care for children based on their medical, cognitive, and behavioral needs. I am involved with the Children's Tumor Foundation (CTF) in promoting clinical care for people with NF, and I currently serve as a member of the CTF Clinical Care Advisory Board. I am also the current chair of the Neurocognitive Committee of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration, which is focused on identifying standardized ways of conducting clinical trials in NF. In addition to working with children with NF, I am also a member of the 22q11.2 Deletion Syndrome Clinic and the eXtraordinarY Kids Clinic, a program for children with XY variants.
Care Philosophy
I strive to collaborate with families, physicians, and other health providers to help children reach their full potential in their social, academic, and behavioral functioning.
General Information
Graduate Schools:
- PsyD, The Virginia Consortium Program in Clinical Psychology (1998)
Undergraduate Schools:
- BA, American University (DC) (1992)
Internships:
- Children's Hospital of Michigan Program (1998)
Fellowships:
- Nationwide Children's Hospital/Ohio State University Program, Pediatric Neuropsychology (2000)
Department: Pediatrics-Neurology